PharmaSGP Holding SE Strengthens Management Board to Accelerate Growth

PharmaSGP Holding SE, a German OTC pharmaceutical company, announced the expansion of its management team. Effective July 1, 2024, Peter Gerckens will join as Chief Commercial Officer (CCO), a newly created position. Gerckens will oversee international markets, sales, and new business ventures.

Peter Gerckens began his career at Procter & Gamble in 2012, later joining McKinsey's Munich office. Before PharmaSGP, he was Managing Director of a medium-sized media company in Munich. Gerckens holds degrees from the University of St. Gallen, the London School of Economics, and Harvard Business School.

PharmaSGP CEO Natalie Weigand stated that the company has generated over €100 million in revenues for the first time in 2023. She expressed confidence in Gerckens's ability to contribute to the company’s ambitious growth targets.